Barriers to hepatitis B vaccine coverage among healthcare workers in the republic of Georgia: An international perspective

Infection Control and Hospital Epidemiology

Volumn 31, Issue 2, 2010, Pages 158-164

  Topuridze, M ^a   Butsashvili, M ^a   Kamkamidze, G ^a   Kajaia, M ^a   Morse, D ^b,c   McNutt, L A ^c  

^a Maternal and Child Care Union   (Georgia)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG SAFETY; FEMALE; GEORGIA (REPUBLIC); HEALTH CARE PERSONNEL; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; LABORATORY TEST; MALE; NORMAL HUMAN; NURSE; PHYSICIAN; PREDICTION; PREVALENCE; QUESTIONNAIRE; VACCINATION;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; FEMALE; GEORGIA (REPUBLIC); HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; MEDICAL STAFF, HOSPITAL; NURSING STAFF, HOSPITAL; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; VACCINATION; YOUNG ADULT;

EID: 75949115489     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/649795     Document Type: Article

References (38)

1. Szmuness W, Prince AM, Grady GF, et al. Hepatitis B infection: a pointprevalence study in 15 US hemodialysis centers. JAMA 1974;227:901-906.
2. Geretty RJ. Hepatitis B transmission between dental or medical workers and patients. Ann Intern Med 1981;95:229-231.
3. Seyckova J, Helc J. Prevalence of viral hepatitis among the hospital staff in CSR between 1980 and 1982. J Hyg Epidemiol Microbiol Immunol 1984;28:267-278.
4. World Health Organization Regional Office for Europe. European health for all database (HFA-DB). Available at: http://data.euro.who.int/hfadb/. Accessed April 29, 2007.
5. Butsashvili M, Tsertsvadze T, McNutt LA, et al. Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors. Eur J Epidemiol 2001;17(7):693-695.
6. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003;157(10):940-943.
7. Braka F, Nanyunja M, Makumbi I, et al. Hepatitis B infection among health workers in Uganda: evidence of the need for health worker protection. Vaccine 2006;24:6930-6937.
8. Suckling RM, Taegtmeyer M, Nguku PM, et al. Susceptibility of healthcare workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake. J Hosp Infect 2006;64(3):271-277.
9. Talaat M, Kandeel A, El-Shoubary W, et al. Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt. Am J Infect Control 2003;31(8):469-474.
10. Simard EP, Miller JT, George PA, et al. Hepatitis B vaccination coverage levels among healthcare workers in the United States, 2002-2003. Infect Control Hosp Epidemiol 2007;28(7):783-790.
11. Batista S, Andreas M, Borges A, et al. Seropositivity for hepatitis B virus, vaccination coverage, and vaccine response in dentists from Campo Grande, Mato Grosso do Sul, Brazil. Mem Inst Oswaldo Cruz 2006;101(3): 263-267.
12. Dannetun E, Tegnell A, Torner A, et al. Coverage of hepatitis B vaccination in Swedish healthcare workers. J Hosp Infect 2006;63(2):201-204.
13. Vranckx R, Jacque P, De Schrijver A, et al. Hepatitis B vaccination coverage in Belgian health care workers. Infection 2004;32(5):278-281.
14. National Center of Disease Control and Public Health. Epidemiological Bulletin. 2005;1:1-10. Available at: http://www.ncdc.ge/GEO/Publications/ Bulletin/bulletin-2005/Bul-1.pdf. Accessed April 29, 2007.
15. Centers for Disease Control and Prevention. Hepatitis B. The Pink Book: Epidemiology and Prevention of Vaccine-Preventable Diseases. Atlanta, GA: CDC; 2005:191-212.
16. Woo EJ, Miller NB, Ball R; VAERS Working Group. Adverse events after hepatitis A, B combination vaccine. Vaccine 2006;24(14):2685-2691.
17. Jain A, Mathur US, Jandwani P, et al. A multicentric evaluation of recombinant DNA hepatitis B vaccine of Cuban origin. Trop Gastroenterol 2000;21(1):14-17.
18. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 2002;347:1477-1482. (Pubitemid 35257586)
19. Hviid A, Stellfeld M, Wohlfahrt J, et al. Childhood vaccination and type 1 diabetes. N Engl J Med 2004;350:1398-1404.
20. Confavreux C, Suissa S, Saddier P, et al. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines In Multiple Sclerosis Study Group. N Engl J Med 2001;344:319-326. (Pubitemid 32107639)
21. Anderson HR, Poloniecki JD, Strachan DP, et al. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health 2001;91: 1126-1129.
22. Vaccine Safety Datalink (VSD) Project. Annual report, 2004-2005.Washington, DC: America's Health Isurance Plans, 2005. Available at: http://www.ahip.org/content/fileviewer.aspx?docidp307&linkidp150678. Accessed April 20, 2007.
23. Vaccine Adverse Event Reporting System (VAERS). Rockville, MD: CDC. Available at: http://vaers.hhs.gov/resources/index. Accessed April 29, 2007.
24. Geier MR, Geier DA, Zahalsky AC. A review of hepatitis B vaccination. Expert Opin Drug Saf 2003;2(2):113-122.
25. World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 2004;79:255-263.
26. World Health Organization. Global Advisory Committee on Vaccine Safety, 12-13 December 2007. Wkly Epidemiol Rec 2008;83:37-44.
27. McMahon BJ, Helminiak C, Wainwright RB, Bulkow L, Trimble BA, Wainwright K. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med 1992;92:254-256.
28. Niu MT, Salive ME, Ellenberg SS. Neonatal deaths after hepatitis B vaccine: the Vaccine Adverse Event Reporting System, 1991-1998. Arch Pediatr Adolesc Med 1999;153:1279-1282.
29. Lewis E, Shinefield HR, Woodruff BA, et al. Safety of neonatal hepatitis B vaccine administration. Pediatr Infect Dis J 2001;20:1049-1054.
30. Zanetti AR. Update on hepatitis B vaccination in Italy 10 years after its implementation. Vaccine 2001;19:2380-2383.
31. Yu AS, Cheung RC, Keeffe EB. Hepatitis B vaccines. Clin Liver Dis 2004;8: 283-300.
32. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997;336:196-204.
33. Shaw FE Jr, Graham DJ, Guess HA, et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination: experience of the first three years. Am J Epidemiol 1988;127:337-352.
34. Gulua N. Case report: encephalomyelitis caused by hepatitis B vaccination. Spirit Lake, Idaho: Vaccination Liberation. Available at: http://www.vaclib.org/basic/Case-Report.doc. Accessed April 29, 2007.
35. Centers for Disease Control and Prevention. Hepatitis B fact sheet. Atlanta, GA: CDC; 2006. Available at: http://www.cdc.gov/hepatitis/Resources/ Professionals/PDFs/ABCTable-BW.pdf. Accessed April 29, 2007.
36. Centers for Disease Control and Prevention. Vaccine information statement. Atlanta, GA: CDC; 2007. Available at: http://www.cdc.gov/vaccines/ pubs/vis/downloads/vis-hep-b.pdf. Accessed April 29, 2007.
37. Azap A, Ergönül O, Memikoǧlu KO, et al. Occupational exposure to blood and body fluids among health care workers in Ankara, Turkey. Am J Infect Control 2005;33(1):48-52.
38. Erdem Y, Talas MS. Blunt and penetrating object injuries in housekeepers working in a Turkish university hospital. Am J Infect Control 2006;34(4): 208-214.